TGIF! A collaborative team, made up of researchers from the University of Michigan (UM), the Adolphe Merkle Institute at the University of Fribourg, and UC San Diego, was inspired by the eel to develop a transparent, flexible electric device, using 3D bioprinting technology, that could one day lead to soft, biocompatible power sources, in the form of gel packs, for implanted health monitors, future cyborgs, and other applications:
BICO’s Post
More Relevant Posts
-
🤖Embark on an exciting journey to shape the future of the laboratory landscape at Biosero. If you are passionate about people and cutting-edge automation solutions, explore their career opportunities and join a team with relentless commitment to excellence. By joining the team, you will have the chance to contribute to mission-critical discoveries and make a meaningful impact. Explore open positions: https://lnkd.in/dSE2QB88 #LaboratoryAutomation #Robotics #hiring
-
-
🤖The integration of robots and machines through scheduling software has transformed the way scientific research is conducted. By automating manual tasks and facilitating uninterrupted research, they have boosted efficiency and productivity while minimizing the occurrence of significant errors and inconsistencies. The team at Biosero is helping labs around the world usher in an era of automation with solutions, like Green Button Go. This software empowers researchers to seamlessly integrate, control, and schedule multiple instruments and devices within their lab environment from a single interface. With Green Button Go, researchers can embrace true automation, empowering them to step away and concentrate on their research without distraction. Learn more: https://lnkd.in/dpEfw6-R #software #labautomation #efficiency #laborchestration #Robotics #GreenButtonGo
-
-
Are you ready to advance your career? Explore exciting job opportunities across the entire BICO group. Join the CYTENA team and play a pivotal role in shaping how labs develop new therapies and conduct cutting-edge research. Check out the open positions and become a CYTENO https://lnkd.in/ePMSpDpr
-
-
Biologics account for many of the best-selling drugs worldwide. This emphasizes the importance of optimized cell line development workflows for producing the next generation of cell and gene therapies, monoclonal antibodies, and other modern therapeutics. To address this CYTENA developed the UP.SIGHT, an all-in-one solution for efficient and automated single-cell dispensing and clone selection. Seamlessly integrated into GMP-compatible workflows, the UP.SIGHT streamlines workflows with over 97% single-cell isolation efficiency in under 2 minutes. Watch the video to better understand how the UP.SIGHT works. #CellIsolation #SingleCellCloning #LabInnovation #SingleCellDispenser
-
Anders Fogelberg has been appointed as Chief Commercial Officer (CCO). Commercial excellence has been defined as one of the top strategic priorities for BICO and this position is pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Anders will join BICO on June 13, 2024. Read the press release https://lnkd.in/dktvSZKU
-
Looking to take the next step in your career? Explore the different openings across the BICO group and see how you can make an impact on creating the future of health https://lnkd.in/dQTidcTa
-
-
We are delighted to welcome Catharina Nordlund as our new Chief HR Officer on her first day as part of BICO. Invest in People & Culture has been identified as one of the Group’s strategic priorities. Catharina will have a key role being responsible for shaping and executing BICO’s global HR strategy in order to build a people and high-performance culture. Join us in welcoming Catharina to the BICO family! #welcometotheteam #CHRO #newCHRO #executivemanagement #BICO #peopleandculture
-
In the ever-advancing world of biopharmaceutical research, cell line development (CLD) is taking the center stage across various application areas. It's playing a pivotal role in the development of biotherapeutics, encompassing monoclonal antibodies, vaccines, and biologics. Researchers, in their pursuit of improving the productivity of biopharmaceuticals, have turned to cell-based assays and the screening of different clones. However, the traditional manual screening methods used for CLD are both time-consuming and labor-intensive. To alleviate these challenges, CYTENA and Biosero have collaborated to offer a turnkey automation solution: the C.STATION. The C.STATION manages the entire CLD process, from single-cell cloning to selecting and scaling the best-performing clones. Watch the video to learn how this bioconvergant solution streamlines the CLD workflow, minimizing manual labor while enhancing reproducibility and traceability.
-
Our CEO, Maria Forss, recently sat down with 3DPrint.com for an exclusive interview. Read the full article to learn more about her journey since taking the helm at BICO in November 2023 and her vision of leveraging BICO’s rich portfolio and unique market position to significantly impact life-saving research and development. https://lnkd.in/derM_pjM
-
-
Exciting updates from the 𝐁𝐈𝐂𝐎𝐯𝐞𝐫𝐬𝐞! Discover the latest and most relevant content from our BICO companies! 🚀 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐬𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭: Heart valve disease, a widespread condition, results in cardiovascular-related fatalities. While traditional mechanical replacements save lives, they present long-term challenges. A team of researchers at the Université de Montréal tackled these issues using bioprinting to create heart valve replacements. Read the full story https://lnkd.in/duWFYM-F 𝐍𝐞𝐰 𝐏𝐫𝐨𝐝𝐮𝐜𝐭: Now completely revamped, reengineered, and reimagined from the ground up, UP.SIGHT is set to elevate your entire CLD workflow from cloning to top clone selection. Learn more https://lnkd.in/eCPjqAP3 𝐁𝐥𝐨𝐠: Unlocking the secrets of cancer cells, researchers unveil a novel technique, scCUTseq, that precisely maps DNA copy number changes within individual cells, offering insights into cancer development and paving the way for new treatment strategies. Read the full blog https://lnkd.in/d9fZVdMf 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐧𝐨𝐭𝐞: Gene synthesis can be slow, expensive, and inaccurate, which can hold back innovation. Check out this innovative approach for a scalable process for highly parallel DNA synthesis on silicon semiconductor chips https://lnkd.in/dZVXtpgg #BICOverse #bioprinting #biotechnology #automation #biosciences #customerspotlight #applicationnote #DNAsynthesis CELLINK, CYTENA, DISPENDIX, SCIENION
